572 related articles for article (PubMed ID: 31128485)
21. Chinese herbal medicine therapy and the risk of overall mortality for patients with liver cancer who underwent surgical resection in Taiwan.
Tsai FJ; Liu X; Chen CJ; Li TM; Chiou JS; Chuang PH; Ko CH; Lin TH; Liao CC; Huang SM; Liang WM; Lin YJ
Complement Ther Med; 2019 Dec; 47():102213. PubMed ID: 31780007
[TBL] [Abstract][Full Text] [Related]
22. Aggressive therapeutic strategies improve the survival of hepatocellular carcinoma patients with performance status 1 or 2: a propensity score analysis.
Hsu CY; Liu PH; Lee YH; Hsia CY; Huang YH; Chiou YY; Tsai YJ; Nagaria TS; Huo TI
Ann Surg Oncol; 2015 Apr; 22(4):1324-31. PubMed ID: 25326394
[TBL] [Abstract][Full Text] [Related]
23. Adjunctive traditional Chinese medicine therapy improves survival of liver cancer patients.
Liao YH; Lin CC; Lai HC; Chiang JH; Lin JG; Li TC
Liver Int; 2015 Dec; 35(12):2595-602. PubMed ID: 25875878
[TBL] [Abstract][Full Text] [Related]
24. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
[TBL] [Abstract][Full Text] [Related]
25. The Impact of Combined Transarterial Chemoembolization on the Overall Survival of Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib.
Chen L; Su H; Shao H; Xu K; Liang S; Liu J
Hepatogastroenterology; 2014 May; 61(131):802-8. PubMed ID: 26176077
[TBL] [Abstract][Full Text] [Related]
26. Huaier granule prevents the recurrence of early-stage hepatocellular carcinoma after thermal ablation: A cohort study.
Wang Z; Yu XL; Zhang J; Cheng ZG; Han ZY; Liu FY; Dou JP; Kong Y; Dong XJ; Zhao QX; Yu J; Liang P; Tang WZ
J Ethnopharmacol; 2021 Dec; 281():114539. PubMed ID: 34428522
[TBL] [Abstract][Full Text] [Related]
27. Fuzheng Jiedu Xiaoji formulation inhibits hepatocellular carcinoma progression in patients by targeting the AKT/CyclinD1/p21/p27 pathway.
Yang X; Feng Y; Liu Y; Ye X; Ji X; Sun L; Gao F; Zhang Q; Li Y; Zhu B; Wang X
Phytomedicine; 2021 Jul; 87():153575. PubMed ID: 33984593
[TBL] [Abstract][Full Text] [Related]
28. ESTABLISHMENT AND EVALUATION OF ORTHOTOPIC HEPATOCELLULAR CARCINOMA AND DRUG-INDUCED HEPATOCELLULAR CARCINOMA IN MICE WITH SPLEEN-DEFICIENCY SYNDROME IN TRADITIONAL CHINESE MEDICINE.
Luo H; Chen Y; Sun B; Xiang T; Zhang S
Afr J Tradit Complement Altern Med; 2017; 14(1):165-173. PubMed ID: 28480394
[TBL] [Abstract][Full Text] [Related]
29. Utilization of Chinese herbal medicine and its association with the risk of fracture in patients with Parkinson's disease in Taiwan.
Chen KY; Wu MY; Yang PS; Chiang JH; Hsu CY; Chen CY; Yen HR
J Ethnopharmacol; 2018 Nov; 226():168-175. PubMed ID: 30118835
[TBL] [Abstract][Full Text] [Related]
30. The use of adjunctive traditional Chinese medicine therapy and survival outcome in patients with head and neck cancer: a nationwide population-based cohort study.
Lin HC; Lin CL; Huang WY; Shangkuan WC; Kang BH; Chu YH; Lee JC; Fan HC; Kao CH
QJM; 2015 Dec; 108(12):959-65. PubMed ID: 25862772
[TBL] [Abstract][Full Text] [Related]
31. Associations between prescribed Chinese herbal medicine and risk of hepatocellular carcinoma in patients with chronic hepatitis B: a nationwide population-based cohort study.
Tsai TY; Livneh H; Hung TH; Lin IH; Lu MC; Yeh CC
BMJ Open; 2017 Jan; 7(1):e014571. PubMed ID: 28122837
[TBL] [Abstract][Full Text] [Related]
32. Targeting Tumor Immunosuppressive Microenvironment for the Prevention of Hepatic Cancer: Applications of Traditional Chinese Medicines in Targeted Delivery.
Zhang LY; Zhang JG; Yang X; Cai MH; Zhang CW; Hu ZM
Curr Top Med Chem; 2020; 20(30):2789-2800. PubMed ID: 33076809
[TBL] [Abstract][Full Text] [Related]
33. A Case of Recurrent Hepatocellular Carcinoma Acquiring Complete Remission of Target Lesion With Treatment With Traditional Chinese Medicine.
Jianxin C; Qingxia X; Junhui W; Qinhong Z
Integr Cancer Ther; 2017 Dec; 16(4):597-604. PubMed ID: 27444311
[TBL] [Abstract][Full Text] [Related]
34. The Effect of Transarterial Chemoembolization in Combination With Kang'ai Injection on Patients With Intermediate Stage Hepatocellular Carcinoma: A Prospective Study.
Wan YM; Li YH; Xu ZY; Wu HM; Xu Y; Yang M; Wu XN
Integr Cancer Ther; 2018 Jun; 17(2):477-485. PubMed ID: 29108428
[TBL] [Abstract][Full Text] [Related]
35. Hepatic arterial infusion of oxaliplatin plus fluorouracil/leucovorin vs. sorafenib for advanced hepatocellular carcinoma.
Lyu N; Kong Y; Mu L; Lin Y; Li J; Liu Y; Zhang Z; Zheng L; Deng H; Li S; Xie Q; Guo R; Shi M; Xu L; Cai X; Wu P; Zhao M
J Hepatol; 2018 Jul; 69(1):60-69. PubMed ID: 29471013
[TBL] [Abstract][Full Text] [Related]
36. Prognostic factors of spontaneously ruptured hepatocellular carcinoma.
Han XJ; Su HY; Shao HB; Xu K
World J Gastroenterol; 2015 Jun; 21(24):7488-94. PubMed ID: 26139994
[TBL] [Abstract][Full Text] [Related]
37. Effects of Chinese herbal medicine therapy on survival and hepatic outcomes in patients with hepatitis C virus infection in Taiwan.
Tsai FJ; Cheng CF; Chen CJ; Lin CY; Wu YF; Li TM; Chuang PH; Wu YC; Lai CH; Liu X; Tsang H; Lin TH; Liao CC; Huang SM; Li JP; Lin JC; Lin CC; Liang WM; Lin YJ
Phytomedicine; 2019 Apr; 57():30-38. PubMed ID: 30668320
[TBL] [Abstract][Full Text] [Related]
38. Chinese herbal medicine, Jianpi Ligan decoction, improves prognosis of unresectable hepatocellular carcinoma after transarterial chemoembolization: a retrospective study.
Tang CW; Zhu M; Feng WM; Bao Y; Zheng YY
Drug Des Devel Ther; 2016; 10():2461-6. PubMed ID: 27536066
[TBL] [Abstract][Full Text] [Related]
39. Chinese Herbal Medicine, Jian Pi Li Gan Decoction, Improved Survival of Nonresectable Hepatocellular Cancer After Radiofrequency Ablation: A Retrospective Study.
Tang C; Feng W; Qin L; Bao Y
Integr Cancer Ther; 2018 Jun; 17(2):431-436. PubMed ID: 28745082
[TBL] [Abstract][Full Text] [Related]
40. Comparable effects of Jiedu Granule, a compound Chinese herbal medicine, and sorafenib for advanced hepatocellular carcinoma: A prospective multicenter cohort study.
Zhao HT; Meng YB; Zhai XF; Cheng BB; Yu SS; Yao M; Yin HX; Wan XY; Yang YK; Liu H; Shen F; Ling CQ
J Integr Med; 2020 Jul; 18(4):319-325. PubMed ID: 32532615
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
